VRd vs. VPd as induction therapy in high risk newly diagnosed multiple myeloma
Crossref DOI link: https://doi.org/10.1038/s41598-025-85398-0
Published Online: 2025-03-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Chun Yan
Zhong, Long
Chen, Dan Gui
Yao, Fu Sheng
Yan, Hong
Text and Data Mining valid from 2025-03-22
Version of Record valid from 2025-03-22
Article History
Received: 2 October 2024
Accepted: 2 January 2025
First Online: 22 March 2025
Declarations
:
: The authors declare no competing interests.